logo
Share SHARE
FONT-SIZE Plus   Neg

Bio-Reference Labs. Posts Lower Q1 Profit - Quick Facts

Bio-Reference Laboratories Inc.'s (BRLI) first-quarter net income decreased to $7.36 million or $0.26 per share from $7.99 million or $0.28 per share last year.

The company recorded quarterly revenues of $149.92 million, a 23% increase over $121.66 million reported in the prior-year quarter.

On average, 5 analysts polled by Thomson Reuters expected earnings per share of $0.21 on $143.13 million revenue for the quarter. Analysts' estimates typically exclude one-time items.

Marc Grodman, MD, CEO, commented: "The milder than normal weather conditions, particularly in the Northeast, have contributed to the strength of our Q1 results when compared to our prior year results. However, and more importantly, the overall success of all our business units has been the primary reason for our strong financial results."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Leaders of the Senate Health Committee revealed Tuesday they have reached an agreement on legislation to provide short-term stability to Obamacare. Committee Chairman Lamar Alexander, R-Tenn., and ranking member Patty Murray, D-Wash., announced the bipartisan agreement. Activist investor Rudolf Bohli is reportedly targeting Switzerland's second largest bank Credit Suisse. Bloomberg reported that Bohli has 0.2 percent stake in Credit Suisse that comes around 100 million francs or around $102 million. Australia's flag carrier Qantas Airways Ltd. on Tuesday took delivery of its first Boeing 787-9 Dreamliner aircraft, noting that the game-changing aircraft will open up new routes and new levels of comfort for travelers. The new aircraft will enable Qantas to operate Australia's first regular non-stop flights to Europe.
comments powered by Disqus
Follow RTT